German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Perrigo

Market Cap: €1.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Grand Pharmaceutical Group

Market Cap: €18.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Indivior Pharmaceuticals

Market Cap: €4.9b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Prestige Consumer Healthcare

Market Cap: €2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Bavarian Nordic

Market Cap: €13.7b

Develops, manufactures, and supplies life-saving vaccines.

United Laboratories International Holdings

Market Cap: €18.1b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Trajan Group Holdings

Market Cap: €32.0m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

ANI Pharmaceuticals

Market Cap: €1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

China Resources Pharmaceutical Group

Market Cap: €30.5b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Cresco Labs

Market Cap: €404.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Bausch Health Companies

Market Cap: €1.7b

Operates as a diversified specialty pharmaceutical and medical device company.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €194.3m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

China Medical System Holdings

Market Cap: €29.2b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

CorMedix

Market Cap: €564.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Consun Pharmaceutical Group

Market Cap: €11.5b

Produces and sells pharmaceutical products in Mainland China.

Vetoquinol

Market Cap: €844.9m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Bavarian Nordic

Market Cap: €13.7b

Develops, manufactures, and supplies life-saving vaccines.

Santen Pharmaceutical

Market Cap: €606.1b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

High Tide

Market Cap: €262.7m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Gossamer Bio

Market Cap: €101.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

Otsuka Holdings

Market Cap: €5.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

UCB

Market Cap: €41.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: €18.3b

Joincare Pharmaceutical Group Industry Co.,Ltd.

GSK

Market Cap: €77.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Trulieve Cannabis

Market Cap: €1.5b

Operates as a cannabis retailer in the United States.

GSK

Market Cap: €77.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Fortrea Holdings

Market Cap: €1.9b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

ACADIA Pharmaceuticals

Market Cap: €4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Hikma Pharmaceuticals

Market Cap: €3.4b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

TerrAscend

Market Cap: €249.9m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.